Kidney Week

Oral Abstract Session

Late-Breaking Research Orals - 2

November 07, 2025 | 04:30 PM - 06:00 PM

Location: Grand Ballroom C, Convention Center

Session Description

Late-Breaking Research Orals - 2

Note: Continuing education credits are not being offered for this session.

Learning Pathway(s)

• Other

Moderators

• Keisha L. Gibson, MD, MPH, FASN
• Kalani L. Raphael, MD, MS, FASN

Presentations

• Efficacy and Safety of the Oral Small-Molecule GLP-1 Receptor Agonist HRS-7535 in Patients with Diabetic Kidney Disease
  04:30 PM - 04:42 PM
  
  • Xiaoying Du, MA

Efficacy and Safety of the Oral Small-Molecule GLP-1 Receptor Agonist HRS-7535 in Patients with Diabetic Kidney Disease

November 07, 2025 | 04:30 PM - 04:42 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Mechanistic Effects of Semaglutide on Kidney Disease in Type 2 Diabetes: The REMODEL Trial
  04:42 PM - 04:54 PM
  
  • Katherine R. Tuttle, MD, FASN

Mechanistic Effects of Semaglutide on Kidney Disease in Type 2 Diabetes: The REMODEL Trial

November 07, 2025 | 04:42 PM - 04:54 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Serum Potassium, Hyperkalemia, and the Effect of Hyperkalemia on Treatment Efficacy with Empagliflozin, Finerenone, or Both: A CONFIDENCE Trial Report
  04:54 PM - 05:06 PM
  
  • Rajiv Agarwal, MD, MS, FASN

Serum Potassium, Hyperkalemia, and the Effect of Hyperkalemia on Treatment Efficacy with Empagliflozin, Finerenone, or Both: A CONFIDENCE Trial Report

November 07, 2025 | 04:54 PM - 05:06 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Lorundrostat, a Novel Aldosterone Synthase Inhibitor (ASI), in Participants with Uncontrolled Hypertension, CKD, and Albuminuria: Results from Explore-CKD
  05:06 PM - 05:18 PM
  
  • Matthew R. Weir, MD

Lorundrostat, a Novel Aldosterone Synthase Inhibitor (ASI), in Participants with Uncontrolled Hypertension, CKD, and Albuminuria: Results from Explore-CKD

November 07, 2025 | 05:06 PM - 05:18 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Impact of Glomerular Filtration Rate and Albuminuria on the Effects of SGLT2 Inhibitors on Kidney Outcomes
  05:18 PM - 05:30 PM
  
  • Brendon Lange Neuen, MBBS, MS, PhD, FASN

Impact of Glomerular Filtration Rate and Albuminuria on the Effects of SGLT2 Inhibitors on Kidney Outcomes

November 07, 2025 | 05:18 PM - 05:30 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Global, Regional, and National Burden of CKD in Adults: Updated Systematic Analyses of the Global Burden of Disease Study
  05:30 PM - 05:42 PM
  
  • Patrick Barry Mark, MBChB, PhD

Global, Regional, and National Burden of CKD in Adults: Updated Systematic Analyses of the Global Burden of Disease Study

November 07, 2025 | 05:30 PM - 05:42 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Community Health Worker Support for Latino Individuals on Dialysis: The Navigate-Kidney Randomized Clinical Trial
  05:42 PM - 05:54 PM
  
  • Lilia Cervantes, MD

Community Health Worker Support for Latino Individuals on Dialysis: The Navigate-Kidney Randomized Clinical Trial

November 07, 2025 | 05:42 PM - 05:54 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.